NEW YORK (Reuters Health) – Definitive chemoradiotherapy is an effective treatment than can be dispensed with no significant toxicity in elderly patients with locally advanced esophageal cancer, according…
NEW YORK (Reuters Health) – The incidence of non-Hodgkin’s lymphoma (NHL) is increased somewhat in patients with diabetes, according to results of a meta-analysis published in Diabetes Care…
NEW YORK (Reuters Health) – The results of a case-control study suggest that the benefit of colonoscopy in preventing colorectal cancer deaths is largely limited to left-sided malignancies.…
NEW YORK (Reuters Health) – Patients who are undernourished after experiencing an acute stroke benefit from intensive protein and energy supplementation during inpatient rehabilitation, according to results of…
NEW YORK (Reuters Health) – Intensive treatment to lower low-density lipoprotein cholesterol (LDL-C) reduces carotid intima-media thickness (CIMT) in patients with type 2 diabetes, according to a secondary…
NEW YORK (Reuters Health) – Results of a phase I trial suggest that intralesional transfer of plasmid interleukin (IL)-12 enhanced by electroporation for treatment of metastatic melanoma is…
NEW YORK (Reuters Health) – A 2.5-mg dose of terbutaline at bedtime appears to prevent hypoglycemia during the night in patients with aggressively treated type 1 diabetes, without…
NEW YORK (Reuters Health) – The results of a new study suggest that just one dose of the vaccinia vaccine against smallpox provides immunity for as long as…
NEW YORK (Reuters Health) – Long-term treatment with fenofibrate does not seem to reduce atherosclerosis, inflammation or endothelial dysfunction in patients with type 2 diabetes, according to a…
NEW YORK (Reuters Health) ? Laparoscopic antireflux surgery (LARS) and the proton pump inhibitor (PPI) esomeprazole are similarly effective, safe, and well tolerated strategies for the management of…
